Why BreastDefense?

For breast cancer, the most common screening method - mammography - is alarmingly inaccurate. The New England Journal of Medicine estimates 31% of all breast cancer cases may be misdiagnosed.

Approximately 39 million mammography’s are preformed each year in the USA.
Thousands of women are being misdiagnosed.

This needs to change.

With a simple blood draw BreastDefense aims to distinguish benign and malignant tissue with 99% accuracy.

The Harm of Over-Diagnosis

What many women don't realize is the potential harm of over diagnosis, not to be confused with false positives. It is when a mammogram detects non-invasive or benign cancer which is unlikely to cause a problem. Currently, there is no way to tell, which can lead to unnecessary treatment.